| Pancreatic cancer microenvironment: a current dilemma B Uzunparmak, IH Sahin Clinical and translational medicine 8 (1), 2, 2019 | 93 | 2019 |
| Effects of the administration of high-dose interleukin-2 on immunoregulatory cell subsets in patients with advanced melanoma and renal cell cancer HJJ van derVliet, HB Koon, SC Yue, B Uzunparmak, V Seery, MA Gavin, ... Clinical Cancer Research 13 (7), 2100-2108, 2007 | 86 | 2007 |
| Caspase-8 loss radiosensitizes head and neck squamous cell carcinoma to SMAC mimetic–induced necroptosis B Uzunparmak, M Gao, A Lindemann, K Erikson, L Wang, E Lin, SJ Frank, ... JCI insight 5 (23), 2020 | 35 | 2020 |
| Structure/function analysis of PARP-1 in oxidative and nitrosative stress-induced monomeric ADPR formation B Buelow, B Uzunparmak, M Paddock, AM Scharenberg PLoS One 4 (7), e6339, 2009 | 19 | 2009 |
| HER2-low expression in patients with advanced or metastatic solid tumors B Uzunparmak, C Haymaker, G Raso, S Masciari, L Wang, H Lin, A Gorur, ... Annals of Oncology 34 (11), 1035-1046, 2023 | 12 | 2023 |
| Comment on: α-smooth muscle actin expression and desmoplastic stromal reaction in pancreatic cancer: results from the CONKO-001 study IH Sahin, B Uzunparmak British journal of cancer 112 (11), 1838-1838, 2015 | 5 | 2015 |
| Loss of Caspase-8 function in combination with SMAC mimetic treatment sensitizes Head and Neck Squamous Carcinoma to radiation through induction of necroptosis B Uzunparmak, M Gao, A Lindemann, K Erikson, L Wang, E Lin, SJ Frank, ... bioRxiv, 2020.04. 17.039040, 2020 | 2 | 2020 |
| Co-clinical Trial of Novel Bispecific Anti-HER2 Antibody Zanidatamab in Patient-Derived Xenografts TP DiPeri, KW Evans, B Wang, M Zhao, A Akcakanat, MG Raso, YQ Rizvi, ... Cancer discovery 14 (5), 828-845, 2024 | | 2024 |
| Comprehensive genomic and transcriptomic analysis to guide therapy for patients with metastatic solid tumors B Uzunparmak, F Su, AM Johnson, K Nomie, N Fowler, L Kontselidze, ... Cancer Research 84 (6_Supplement), 939-939, 2024 | | 2024 |
| Limited Independent Follow-Up with Germline Testing of Variants Detected in BRCA1 and BRCA2 by Tumor-Only Sequencing CJ Nowlen, M Daniels, B Uzunparmak, EE Ileana Dumbrava, Y Yuan, ... Journal of Immunotherapy and Precision Oncology 7 (1), 7-17, 2024 | | 2024 |
| Abstract B126: Co-clinical trial of novel bispecific anti-HER2 antibody Zanidatamab in Patient-Derived Xenografts TP DiPeri, KW Evans, B Wang, M Zhao, A Akcakanat, MG Raso, YQ Rizvi, ... Molecular Cancer Therapeutics 22 (12_Supplement), B126-B126, 2023 | | 2023 |
| Abstract B18: Loss of caspase-8 renders head and neck squamous cell carcinomas susceptible to necroptosis B Uzunparmak, JN Myers, CR Pickering Clinical Cancer Research 26 (12_Supplement_2), B18-B18, 2020 | | 2020 |
| Comment on “ERK and p38MAPK combine to improve survival in patients with BRAF mutant colorectal cancer” B Uzunparmak, IH Sahin British journal of cancer 119 (7), 908-908, 2018 | | 2018 |
| Caspase-8 is a novel candidate driver gene in head and neck squamous cell carcinoma B Uzunparmak, A Lindemann, MJ Frederick, JN Myers, CR Pickering Clinical Cancer Research 23 (23_Supplement), 04-04, 2017 | | 2017 |
